Results of a Phase I Study of Obinutuzumab, Venetoclax, and Lenalidomide in Relapsed and Refractory B-Cell Non-Hodgkin Lymphoma
暂无分享,去创建一个
F. Awan | R. Baiocchi | K. Blum | B. Christian | S. Jaglowski | N. Epperla | K. Maddocks | J. Brammer | B. William | S. Ayyappan | Ying Huang